Spira, A. Et Al. 2018. Expanded Efficacy and Safety Analysis of PACIFIC Based on a PD-L1 Cutpoint of 25%. JOURNAL OF THORACIC ONCOLOGY , vol.13, no.10 .

Spira, A., Planchard, D., Cho, B. C., Ozguroglu, M., Daniel, D., Villegas, A., ... Vicente, D.(2018). Expanded Efficacy and Safety Analysis of PACIFIC Based on a PD-L1 Cutpoint of 25%. JOURNAL OF THORACIC ONCOLOGY , vol.13, no.10.

Spira, A. Et Al. "Expanded Efficacy and Safety Analysis of PACIFIC Based on a PD-L1 Cutpoint of 25%," JOURNAL OF THORACIC ONCOLOGY , vol.13, no.10, 2018

Spira, A. Et Al. "Expanded Efficacy and Safety Analysis of PACIFIC Based on a PD-L1 Cutpoint of 25%." JOURNAL OF THORACIC ONCOLOGY , vol.13, no.10, 2018

Spira, A. Et Al. (2018) . "Expanded Efficacy and Safety Analysis of PACIFIC Based on a PD-L1 Cutpoint of 25%." JOURNAL OF THORACIC ONCOLOGY , vol.13, no.10.

@article{article, author={A. Spira Et Al. }, title={Expanded Efficacy and Safety Analysis of PACIFIC Based on a PD-L1 Cutpoint of 25%}, journal={JOURNAL OF THORACIC ONCOLOGY}, year=2018}